• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Venus Remedies Limited — Important, 04-06-2026: Updates

    04-06-2026 | 04:29 pm

    Venus Remedies (VENUSREM) renewed crucial R&D recognition, validating its commitment to antimicrobial resistance research. This supports innovative drug development, including USFDA-designated VRP-034, signaling a strong future pipeline.

    No comments yet. Be the first to comment!

    All announcements from Venus Remedies Limited